Vext Science, Inc.
VEXTF
$0.095
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 39.17M | 36.00M | 34.22M | 33.33M | 34.09M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 39.17M | 36.00M | 34.22M | 33.33M | 34.09M |
| Cost of Revenue | 29.23M | 27.01M | 25.50M | 25.77M | 25.42M |
| Gross Profit | 9.94M | 8.99M | 8.72M | 7.56M | 8.67M |
| SG&A Expenses | 11.12M | 11.44M | 16.09M | 15.78M | 13.66M |
| Depreciation & Amortization | 8.90M | 8.74M | 8.58M | 8.16M | 6.95M |
| Other Operating Expenses | 328.10K | 374.00K | -1.00K | -7.00K | -13.00K |
| Total Operating Expenses | 49.58M | 47.55M | 50.16M | 49.70M | 46.02M |
| Operating Income | -10.41M | -11.55M | -15.94M | -16.37M | -11.93M |
| Income Before Tax | -18.01M | -21.12M | -5.99M | -6.15M | -2.24M |
| Income Tax Expenses | 1.43M | 1.31M | 1.60M | 778.70K | -235.20K |
| Earnings from Continuing Operations | -19.44 | -22.44 | -7.59 | -6.93 | -2.01 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.44M | -22.44M | -7.59M | -6.93M | -2.01M |
| EBIT | -10.41M | -11.55M | -15.94M | -16.37M | -11.93M |
| EBITDA | 4.07M | 3.00M | -1.70M | -3.42M | -796.30K |
| EPS Basic | -0.08 | -0.09 | -0.03 | -0.03 | -0.01 |
| Normalized Basic EPS | -0.04 | -0.05 | -0.05 | -0.05 | -0.04 |
| EPS Diluted | -0.08 | -0.10 | -0.03 | -0.03 | -0.01 |
| Normalized Diluted EPS | -0.04 | -0.05 | -0.05 | -0.05 | -0.04 |
| Average Basic Shares Outstanding | 985.94M | 963.58M | 925.27M | 829.48M | 733.76M |
| Average Diluted Shares Outstanding | 989.04M | 966.91M | 929.61M | 830.72M | 735.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |